Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€0.34
19.11.22
€0.10
19.11.23
-5.60%
27.02.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
19.11.22 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
19.11.22
€2.00
19.11.23
-41.00%
20.11.23

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
19.11.22 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€6.85
17.11.22
-
17.11.23
-17.52%
27.11.22

Risky Investment
michaelkr 
17.11.22 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€7.15
13.11.22
-
13.11.23
-20.98%
26.11.22

Could be worthwhile Investment >10% per year
Vassago1 
13.11.22 50%
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
13.11.22
€3.00
13.11.23
-0.60%
26.11.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
kostojunior 
13.11.22 80%
buy
Acelrx Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.91
08.11.22
€4.20
08.11.23
23.85%
16.11.22

DomRuinart 
08.11.22 50%
sell
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€38.20
04.11.22
€32.00
31.12.24
6.81%
21.12.22

Could be very worthwhile Investment >20% year
BiotechBee 
04.11.22 60%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.62
03.11.22
-
03.11.23
13.26%
10.11.22

Could be very worthwhile Investment >20% year
Wolf_of_WS 
03.11.22 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€42.60
01.11.22
€55.00
31.12.24
-10.33%
04.11.22

Could be very worthwhile Investment >20% year
BiotechBee 
01.11.22 60%
buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.47
31.10.22
€18.00
31.12.24
19.77%
31.10.22

Could be very worthwhile Investment >20% year
BiotechBee 
31.10.22 60%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€2.68
29.10.22
-
29.10.23
40.63%
30.10.23

Could be worthwhile Investment >10% per year
melinda 
29.10.22 20%
buy
Inventiva SA

Start price
Target price
Perf. (%)
€6.02
27.10.22
-
27.10.23
-42.03%
28.10.23

Could be worthwhile Investment >10% per year
melinda 
27.10.22 20%
buy
Rocket Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€17.96
26.10.22
€28.00
31.12.24
15.29%
08.06.24

Could be very worthwhile Investment >20% year
BiotechBee 
26.10.22 70%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€20.67
26.10.22
€35.00
31.12.24
-41.33%
21.12.22

Could be very worthwhile Investment >20% year
BiotechBee 
26.10.22 70%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.78
25.10.22
€5.00
31.12.24
-23.55%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
25.10.22 50%
buy
Immunic Inc.

Start price
Target price
Perf. (%)
€1.72
24.10.22
-
24.10.23
-21.87%
18.11.22

Risky Investment
Wolf_of_WS 
24.10.22 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€4.50
24.10.23
-3.11%
25.10.23

Could be worthwhile Investment >10% per year
melinda 
24.10.22 20%
buy
XOMA Corp.

Start price
Target price
Perf. (%)
€16.40
24.10.22
€20.00
24.10.23
-6.10%
25.10.23

Could be worthwhile Investment >10% per year
melinda 
24.10.22 20%
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.12
24.10.22
€3.00
24.10.23
-73.07%
25.10.23

Could be worthwhile Investment >10% per year
melinda 
24.10.22 20%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.80
24.10.22
€7.00
24.10.23
18.42%
29.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
dimontalban 
24.10.22 60%
sell
Carmat

Start price
Target price
Perf. (%)
€12.25
22.10.22
€10.00
22.10.23
-72.94%
23.10.23

Could be worthwhile Investment >10% per year
melinda 
22.10.22 50%
sell
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.70
18.10.22
-
18.10.23
0.78%
29.10.22

Capable Management
Probably not worthwhile Investment
Little innovation
Few uniques
me8 
18.10.22 0%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€3.84
17.10.22
-
17.10.23
40.63%
18.05.23

Risky Investment
quelbe60 
17.10.22 50%
sell
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.54
15.10.22
€2.00
15.10.23
-0.88%
29.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
nvestor 
15.10.22 50%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.63
14.10.22
€5.00
14.10.23
-84.59%
15.10.23

Could be worthwhile Investment >10% per year
melinda 
14.10.22 50%